The Latest Breaking News from Rheumatoid Arthritis

Six People with Severe Rheumatoid Arthritis Improved After a Cancer Cell Therapy and Three Stopped Medication

A cancer cell therapy improved disease activity in six people with severe rheumatoid arthritis. Three reached drug-free remission in a phase 1 trial.

Medical Daily · Aug 31

Nationwide Recall Issued for Arthritis Injection Tyenne After Glass Particles Found in Vials

Fresenius Kabi recalled a lot of Tyenne arthritis injection nationwide after glass particles were found. Here is the lot number to check now.

Medical Daily · Aug 14

5 Painful Joint Conditions That Are Commonly Mistaken for Arthritis But Need Different Treatment

Bursitis: The Inflammation That Sits Just Outside the JointBursae are small fluid-filled sacs that cushion the space between bone and soft tissue. When one gets inflamed, a condition called bursitis, the pain lands directly over the joint and feels indistinguishable from arthritis to most people. The shoulder, hip, and knee…

Times Life · Aug 7

CEO of ‘child-safe’ smartphone startup accused of embezzling company funds to buy escort a Lamborghini

Exclusive: ‘I have never felt more betrayed in my entire life,’ Cyber Dive co-founder Derek Jackson told The Independent of ex-business partner Jeffrey Gottfurcht – the first rheumatoid arthritis sufferer to scale Mount Everest

The Independent UK · Jun 15

Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tablets

Concord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approval for rheumatoid arthritis and other conditions is expected to bolster its U.S. market presence and product portfolio, targeting a $500 million market opportunity.

The Economic Times · Jun 10

Immunovant Q4 Earnings Call Highlights

Roivant executives used the company’s fourth-quarter and fiscal-year earnings call to highlight new clinical data from its development portfolio, upcoming readouts and its strengthened balance sheet following a settlement with Moderna. Matthew Klein, CEO of Roivant, said the company has had “a pret

MarketBeat · May 20

Doctors Call This Rheumatoid Arthritis Breakthrough a “Game Changer” for Pain Relief

If you’ve been living with rheumatoid arthritis, you already know how relentless the pain can feel. Stiff joints, swelling, and fatigue can turn even simple...

Saving Advice · Apr 6

Rheumatoid Arthritis Treatment and DMARD Therapy for Flare Prevention and Joint Protection Techniques

Discover how RA treatment, DMARD therapy, physical therapy, and joint protection techniques work together to reduce rheumatoid arthritis flares and support long-term joint health.

Medical Daily · Apr 3

Methotrexate Rheumatoid Arthritis DMARDs Therapy Guide with Methotrexate Side Effects

Informative guide on methotrexate for rheumatoid arthritis covering DMARDs, autoimmune disease drugs, dosing, monitoring, and common methotrexate side effects to support safer long term use.

Medical Daily · Mar 30

5 Prescription Pricing Changes Affecting Seniors With Chronic Conditions

For seniors managing chronic conditions like diabetes, rheumatoid arthritis, or heart disease, 2026 was heralded as a year of victory. The Inflation Reduction Act finally...

Saving Advice · Feb 5